Actualités

CVS Health stock has returned 74.8% over the past year, yet its broader valuation checks lean expensive, so investors are weighing a strong share price run against signals that the stock may already be pricing in a lot of good news. Over the last 12 months, CVS Health has delivered a 74.8% return, which puts recent holders in a strong position and naturally raises the bar for what future returns need to justify today’s price. Expectations around CVS Health’s ability to grow healthcare and...

Microsoft faces an August 11 Copilot lawsuit deadline, days after the biggest one-day market cap gain in US history.

The California governor has told people involved in the suit that blocking the $81 billion deal could harm Hollywood jobs.

A Massachusetts couple who ran an e-commerce newsletter started receiving anonymous packages containing live cockroaches, a fetal pig, and death threats, and it took years before the full scope of who orchestrated the campaign against them came to light.

NEW YORK, July 30 (Reuters) - Coinbase won the dismissal on Thursday of much of a lawsuit in which customers accused the largest U. ‌cryptocurrency exchange of illegally selling securities without registering as an exchange or ‌broker-dealer.

Hims & Hers shares crashed yesterday as the FTC filed a lawsuit against the telehealth provider. Here’s how you should play HIMS stock at current levels.

The FTC has filed a lawsuit against Hims & Hers Health alleging improper sharing of sensitive health data with advertising platforms and deceptive billing practices. Hims & Hers Health has publicly rejected the allegations and issued a formal response defending its data and billing practices. This action represents a new phase of regulatory scrutiny for NYSE:HIMS that investors are assessing alongside the company’s broader telehealth business. Hims & Hers Health, traded on the NYSE under...

Boston Scientific recently reported its second-quarter 2026 results, showing sales of US$5,442 million and net income of US$907 million, alongside issuing a recall of its Rapid Refill Continuous Injection System and initiating a multi-year global restructuring plan aimed at cost efficiencies. While the company raised full-year 2026 net sales growth expectations to approximately 5.5%–6.5%, it also outlined a restructuring program costing up to US$800 million and targeting around US$500...

The U.S. International Trade Commission has opened an investigation into alleged infringement of Netlist memory patents by Super Micro Computer (NasdaqGS:SMCI) and other companies. The case centers on certain memory technologies that may be used in servers and data center hardware. The ITC process can lead to potential import bans or other trade remedies that affect hardware shipments into the U.S. This investigation adds a new legal and regulatory issue for SMCI investors to monitor through...

Johnson & Johnson proposed a $5.5b settlement to resolve tens of thousands of ovarian cancer talc lawsuits. The offer aims to address a decade-long legal dispute involving the company’s talcum powder products. The settlement would require approval from a majority of claimants before it can move forward. For investors watching Johnson & Johnson (NYSE:JNJ), this legal development sits alongside a stock that closed at $265.53 and has recently shown strong momentum. The shares are up 3.9% over...

Warren and Schiff want an SEC investigation into Trump Media's Truth API, the $100,000 paid feed launching August 1. Two precedents show how it ends.

Walmart stock has delivered a strong 151.4% return over the past five years, yet the latest Discounted Cash Flow (DCF) estimate points to the shares trading at a premium to intrinsic value, while market based multiples suggest pricing that is closer to fair. Over the past five years, a 151.4% total return highlights how much of Walmart's long term value story may already be reflected in the share price. Walmart's dominant grocery position and partnerships that support better inventory...

The payout resolves a 2021 civil lawsuit brought by newsletter publishers David and Ina Steiner over a 2019 campaign to silence their reporting

Johnson & Johnson says it will pay an estimated $5.5 billion to settle about 76,000 lawsuits alleging its baby powder and talc caused ovarian cancer.

Johnson & Johnson has set aside $5.5 billion to resolve tens of thousands of US lawsuits alleging that its talcum powder-based products caused ovarian cancer.

The deal covers about 76,000 ovarian cancer claims and requires acceptance by at least 95% of claimants to take effect

Johnson & Johnson has offered $5.5 billion to settle tens of thousands of lawsuits claiming its baby powder and other talcum powder products caused ovarian cancer, the company says.

Target (TGT) is under fresh scrutiny after being named in a lawsuit tied to Nara Organics infant formula that allegedly caused a confirmed case of infant botulism in Washington, which is part of a broader FDA and CDC outbreak investigation. See our latest analysis for Target. The Nara Organics lawsuit lands at a time when Target's share price has a year to date return of 39.63% and a 1 year total shareholder return of 37.63%, while its 5 year total shareholder return is down 36.52%. This...

Johnson & Johnson (J&J) has offered to pay $5.5bn (£4.13bn) to resolve tens of thousands of lawsuits in the US alleging its talcum powder caused ovarian cancer. The company said the settlement covers around 76,000 claims, having already settled most cases alleging its talc contained asbestos and caused mesothelioma. J&J's vice president of litigation, Erik Haas, said the move was motivated by a desire to get closure – describing the claims themselves as "meritless".

In the midst of an expensive AI transformation, the company is grappling with litigation that could cost it billions and force painful changes.

The company said it reached an agreement with firms representing plaintiffs in the outstanding talc cases to pay up to $3 billion in claim payments in 2027, with no further payments due before 2028.

NEW YORK, July 27 (Reuters) - The former JPMorgan Chase banker whose lurid sexual harassment lawsuit went viral added new claims and defendants on Monday, saying the largest U. bank's acceptance of racism and sexual coercion irreparably destroyed his ‌career.

Ford just issued recalls covering nearly a million vehicles, and while that spells trouble for its own shareholders, a handful of publicly traded dealer groups are quietly positioned to profit from every car that rolls into the service bay.

LONDON, July 27 (Reuters) - Elon Musk's Tesla on Monday won its bid to revive a London lawsuit brought against U.S. technology firm InterDigital and a patent licensing platform, seeking a patent

C3.ai, Inc. recently secured a full dismissal of a putative securities class action in the U.S. District Court for the Northern District of California, removing all asserted claims against the company and certain officers. This legal outcome, combined with recent revenue and EPS results that exceeded analyst expectations, reduces uncertainty around C3.ai’s operations and may influence how investors assess its risk profile. We’ll now examine how the full dismissal of the securities lawsuit...

The lawsuit will likely renew debates about whether term employment agreements are enforceable under California. law

Yahoo Finance Senior Reporter Brooke DiPalma explains what you need to know about the recent egg recall, Lamb Weston's (LW) quarterly earnings, and Coors Light's (TAP) partnership with Cheez-It on "beer cheese crackers."

The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s OTTAVA Robotic Surgical System, marking the regulatory clearance of the world’s first table-integrated soft tissue robotic platform. The marketing clearance encompasses multiple general surgery...

Tesla (TSLA) will not face a defect investigation over the manual door release on Model 3 vehicles a

Capital One Financial (NYSE:COF) has been named in a major lawsuit tied to alleged fraud involving the Zelle payments network. The company is identified as a co-owner of Zelle in the case, which focuses on consumer losses linked to disputed transactions. Separately, Capital One agreed to a C$35 million settlement in a Canadian class action related to a prior data breach. Capital One Financial, a large US card issuer and bank with a growing digital footprint, now sits at the center of two...